The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope to patients of an effective treatment for the relentless itching caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback